TTF1 and adenocarcinoma: Further, an increase in the gene dosage of TTF1 in 214 patients with NSCLC (including 174 adenocarcinomas) showed, a higher frequency of increased gene copies at metastatic sites than at primary sites suggesting that sustained TTF1 expression may be crucial for survival of a subset of adenocarcinomas [161].